SMi Reports: Dr Samareh Lajaunias, Director at Combioxin will be speaking at SMi’s 22nd Annual Superbugs & Superdrugs Conference in London in March 2020 The 22nd Annual Superbugs & Superdrugs Conference will convene on 30th […]
SMi Reports: Invitation from conference chair Lynne Ensor for Pharmaceutical Microbiology East Coast 2020 in Boston SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference is scheduled to take place April 29th – 30th, 2020 in […]
Bristol-Myers Squibb announced that its blood cancer treatment lisocabtagene maraleucel (liso-cel) has achieved its primary and secondary endpoints in TRANSCEND NHL 001 study. Liso-cel is an investigational CD19-directed chimeric antigen receptor (CAR) T-cell therapy with […]
Novartis has collaborated with Amazon Web Services (AWS) to digitally transform the manufacturing, supply chain and delivery of its medicines using cloud services. Under the multi-year partnership, Novartis will leverage AWS artificial intelligence (AI) and […]
Gatehouse Bio, a pioneer in next-generation therapeutics, is collaborating with AstraZeneca, a global science-led biopharmaceutical company, to explore the identification of new targets for respiratory and cardiovascular diseases using Gatehouse Bio’s Artificial Intelligence (AI)-powered platform. […]